Approval · Notice of Compliance 22082 · 2019
FINASTERIDE: Notice of Compliance 22082
Issued April 17, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22082
- Date
- April 17, 2019
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Canadian reference product
- PROSCAR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FINASTERIDE | 02350270 | Marketed |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB